ANNUAL REPORT 2017 - ヤクルト本社
ANNUAL REPORT 2017Year ended March 31, 2017Yakult has conducted its business activities around the world in ways based on Dr. Shirota s philosophy Shirota-ism (preventive medicine, the idea that a healthy intestinal tract leads to a long life, and offering products at a price anyone can afford) as explained on the next help to protect people s health in 38 countries and regions, including Japan, as of March 31, 2017. In addition to fermented milk drinks, Yakult operations in Japan today include a pharmaceuticals business, in which we handle anticancer drugs, as well as a cosmetics business.* Probiotics: Live microorganisms that provide health benefits by improving the balance of intestinal Minoru Shirota, successfully strengthened and cultivated Lactobacillus casei strain Shirota while at Kyoto Imperial University School of Medicine (now Kyoto University).
In Phase III, under this basic policy, we will do our utmost to implement strategies and initiatives for each business, achieve performance targets, and meet the expectations of
Download ANNUAL REPORT 2017 - ヤクルト本社
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: